Aisha Goldstein

Bio-Techne Delivers Strong Q3 Performance Amidst Uncertainty, Eyes Future Growth in Core Reagents and Cell Therapy Markets

TECH

Bio-Techne Delivers Strong Q3 Performance Amidst Uncertainty, Eyes Future Growth in Core Reagents and Cell Therapy Markets

Bio-Techne, a leading life science company, has reported a strong third quarter performance, with 6% organic revenue growth despite operating in a relatively uncertain macro environment. According to Kim Kelderman, President and Chief Executive Officer, the company delivered yet another strong quarter with an emphasis on profitability, driven by operational

By Aisha Goldstein